| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |